×
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
S&P 500   3,818.83
DOW   31,029.31
QQQ   283.80
NASDAQ:OGI

OrganiGram Stock Forecast, Price & News

$0.97
-0.04 (-3.96%)
(As of 06/29/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.96
$1.01
50-Day Range
$0.92
$1.52
52-Week Range
$0.91
$3.13
Volume
1.60 million shs
Average Volume
5.01 million shs
Market Capitalization
$304.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.43
30 days | 90 days | 365 days | Advanced Chart

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock Forecast (MarketRank)

Overall MarketRank

1.87 out of 5 stars

Medical Sector

722nd out of 1,432 stocks

Pharmaceutical Preparations Industry

348th out of 685 stocks

Analyst Opinion: 3.3Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
OrganiGram logo

About OrganiGram (NASDAQ:OGI)

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

OGI Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OGI
Fax
N/A
Employees
841
Year Founded
N/A

Company Calendar

Last Earnings
4/12/2022
Today
6/30/2022
Next Earnings (Estimated)
7/12/2022
Fiscal Year End
8/31/2022

Price Target and Rating

Average Stock Price Forecast
$3.43
High Stock Price Forecast
$5.30
Low Stock Price Forecast
$2.25
Forecasted Upside/Downside
+253.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.57142857142857
Research Coverage
7 Analysts

Profitability

Net Income
$-103.09 million
Pretax Margin
-34.16%

Debt

Sales & Book Value

Annual Sales
$62.43 million
Book Value
$1.26 per share

Miscellaneous

Free Float
N/A
Market Cap
$304.30 million
Optionable
Not Optionable
Beta
0.38














OrganiGram Frequently Asked Questions

Should I buy or sell OrganiGram stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OrganiGram stock.
View analyst ratings for OrganiGram
or view top-rated stocks.

What is OrganiGram's stock price forecast for 2022?

7 Wall Street analysts have issued 12-month target prices for OrganiGram's stock. Their OGI stock forecasts range from $2.25 to $5.30. On average, they anticipate OrganiGram's share price to reach $3.43 in the next year. This suggests a possible upside of 253.1% from the stock's current price.
View analysts' price targets for OrganiGram
or view top-rated stocks among Wall Street analysts.

How has OrganiGram's stock price performed in 2022?

OrganiGram's stock was trading at $1.75 at the beginning of 2022. Since then, OGI shares have decreased by 44.6% and is now trading at $0.97.
View the best growth stocks for 2022 here
.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022.
View our earnings forecast for OrganiGram
.

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc. (NASDAQ:OGI) announced its earnings results on Tuesday, April, 12th. The company reported ($0.02) earnings per share for the quarter, hitting the consensus estimate of ($0.02). The business had revenue of $25.04 million for the quarter, compared to the consensus estimate of $24.28 million. OrganiGram had a negative trailing twelve-month return on equity of 12.28% and a negative net margin of 32.87%. During the same period in the previous year, the firm posted ($0.09) earnings per share.
View OrganiGram's earnings history
.

Who are OrganiGram's key executives?

OrganiGram's management team includes the following people:
  • Mr. Derrick W. West CPA, CPA, (CA), Chief Financial Officer (Age 55, Pay $241.86k)
  • Ms. Helen Martin, Chief Legal Officer & Corp. Sec. (Age 44, Pay $226.53k)
  • Mr. Gregory Engel, Special Advisor (Age 57, Pay $453.13k)
  • Mr. Timothy Emberg, Chief Revenue Officer
  • Mr. Paolo De Luca C.A., C.F.A, Chief Strategy Officer (Age 49, Pay $238.66k)
  • Ms. Beena G. Goldenberg, CEO & Director (Age 59)
  • Ms. Nathalie Batten, VP of Operations
  • Amy Schwalm, VP of Investor Relations
  • Ms. Megan Amber McCrae, Sr. VP of Marketing & Communications
  • Tina Shannon, VP of HR

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), (CGC), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $0.97.

How much money does OrganiGram make?

OrganiGram (NASDAQ:OGI) has a market capitalization of $304.30 million and generates $62.43 million in revenue each year. The company earns $-103.09 million in net income (profit) each year or ($0.09) on an earnings per share basis.

How many employees does OrganiGram have?

OrganiGram employs 841 workers across the globe.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for OrganiGram is www.organigram.ca. The company can be reached via phone at (844) 644-4726.

This page (NASDAQ:OGI) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.